Back to Search Start Over

Ferroptosis: a critical mechanism of N6-methyladenosine modification involved in carcinogenesis and tumor progression.

Authors :
Wei, Qingqing
Xue, Changning
Li, Mengna
Wei, Jianxia
Zheng, Lemei
Chen, Shipeng
Duan, Yumei
Deng, Hongyu
Tang, Faqing
Xiong, Wei
Zhou, Ming
Source :
SCIENCE CHINA Life Sciences; Jun2024, Vol. 67 Issue 6, p1119-1132, 14p
Publication Year :
2024

Abstract

Ferroptosis is an iron-dependent regulatory cell necrosis induced by iron overload and lipid peroxidation. It occurs when multiple redox-active enzymes are ectopically expressed or show abnormal function. Hence, the precise regulation of ferroptosis-related molecules is mediated across multiple levels, including transcriptional, posttranscriptional, translational, and epigenetic levels. N<superscript>6</superscript>-methyladenosine (m<superscript>6</superscript>A) is a highly evolutionarily conserved epigenetic modification in mammals. The m<superscript>6</superscript>A modification is commonly linked to tumor proliferation, progression, and therapy resistance because it is involved in RNA metabolic processes. Intriguingly, accumulating evidence suggests that dysregulated ferroptosis caused by the m<superscript>6</superscript>A modification drives tumor development. In this review, we summarized the roles of m<superscript>6</superscript>A regulators in ferroptosis-mediated malignant tumor progression and outlined the m<superscript>6</superscript>A regulatory mechanism involved in ferroptosis pathways. We also analyzed the potential value and application strategies of targeting m<superscript>6</superscript>A/ferroptosis pathway in the clinical diagnosis and therapy of tumors. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
16747305
Volume :
67
Issue :
6
Database :
Complementary Index
Journal :
SCIENCE CHINA Life Sciences
Publication Type :
Academic Journal
Accession number :
177743230
Full Text :
https://doi.org/10.1007/s11427-023-2474-4